Published :
Tables : 45
Figures : 41
Category : Healthcare
No. of Pages : 245
Report Code : HC-1123
Sleeping Aids Market Introduction: Global Sleeping Aids Market is estimated to value over USD 115 Billion by 2027 end and register a CAGR of over 6.5% during the forecast period 2020 to 2027. Stressful lifestyles have reduced the amount of sleeping time an average person needs resulting in sleep disorders like insomnia, sleep apnea and mental disorders like depression and nervous breakdown. These are some of the crucial factors responsible for the significant growth of the sleep aids market globally. Sleeping Aids Market Overview: Product-wise, the market is bifurcated into insomnia treatment drugs, narcolepsy treatment drugs, devices and others. Insomnia treatment drugs segment is further fragmented into doxepin hydrochloride, eszopiclone, ramelteon, triazolam, quazepam and others. The narcolepsy treatment drugs segment is further sub-segmented into Modafinil, sodium Oxybate, Armodafinil and others. The devices segment is sub-segmented into positive airway pressure device and it is further categorised as continuous positive airway pressure (CPAC) device, auto adjusting positive airway pressure (APAP) device and bi-level positive airway pressure (BiPAP) device. The others segment is further bifurcated into mattresses and pillows, chin straps and mouth pieces and nasal devices. Depending on the indication, the market is categorised as insomnia, sleep deprivation, narcolepsy, sleep apnea and others. Narcolepsy segment is likely to grow at a high CAGR during the forecast period. The reason for this is that narcolepsy is found in 1 in 2000 people. It also causes loss of appetite and it creates difficulty in concentrating on work. Therefore, this segment is likely to show some positive market growth. Sleeping Aids Market Regional Insight: The sleeping aids market is anticipated to show substantial growth in the Asia Pacific region owing to the increasing prevalence of sleeping disorders, rise in the geriatric population in the region and surgical awareness regarding sleeping aids products. Sleeping Aids Market Segmentation: By Region • North America • Europe • Asia Pacific • Latin America By Product Type • Insomnia Treatment Drugs • Doxepin Hydrochloride • Eszopiclone • Ramelteon • Triazolam • Zaleplon • Quazepam • Others By Narcolepsy Treatment Drugs • Modafinil • Sodium Oxybate • Armodafinil • Others By Others • Mattresses and Pillows • Chin Straps • Mouth Pieces and Nasal Devices By Indication • Insomnia • Sleep Deprivation • Narcolepsy • Sleep Apnea • Others Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants Key Market Players: • Pfizer Inc. • ResMed Inc. • Merck & Co. Inc. • GlaxoSmithKline Plc. • Fisher and Paykel Healthcare • EarlySense Ltd. • SleepMed FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global sleeping aids market by Product Type, By Narcolepsy Treatment Drugs, By Others, by Indication and by Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and Latin America • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Global Sleeping Aids Market is estimated to value over USD 115 Billion by 2027 end and register a CAGR of over 6.5% during the forecast period 2020 to 2027. Stressful lifestyles have reduced the amount of sleeping time an average person needs resulting in sleep disorders like insomnia, sleep apnea and mental disorders like depression and nervous breakdown. These are some of the crucial factors responsible for the significant growth of the sleep aids market globally.
Sleeping Aids Market Overview: Product-wise, the market is bifurcated into insomnia treatment drugs, narcolepsy treatment drugs, devices and others. Insomnia treatment drugs segment is further fragmented into doxepin hydrochloride, eszopiclone, ramelteon, triazolam, quazepam and others. The narcolepsy treatment drugs segment is further sub-segmented into Modafinil, sodium Oxybate, Armodafinil and others. The devices segment is sub-segmented into positive airway pressure device and it is further categorised as continuous positive airway pressure (CPAC) device, auto adjusting positive airway pressure (APAP) device and bi-level positive airway pressure (BiPAP) device. The others segment is further bifurcated into mattresses and pillows, chin straps and mouth pieces and nasal devices.
Depending on the indication, the market is categorised as insomnia, sleep deprivation, narcolepsy, sleep apnea and others. Narcolepsy segment is likely to grow at a high CAGR during the forecast period. The reason for this is that narcolepsy is found in 1 in 2000 people. It also causes loss of appetite and it creates difficulty in concentrating on work. Therefore, this segment is likely to show some positive market growth.
Sleeping Aids Market Regional Insight: The sleeping aids market is anticipated to show substantial growth in the Asia Pacific region owing to the increasing prevalence of sleeping disorders, rise in the geriatric population in the region and surgical awareness regarding sleeping aids products.
Sleeping Aids Market Segmentation: By Region • North America • Europe • Asia Pacific • Latin America
By Product Type • Insomnia Treatment Drugs • Doxepin Hydrochloride • Eszopiclone • Ramelteon • Triazolam • Zaleplon • Quazepam • Others
By Narcolepsy Treatment Drugs • Modafinil • Sodium Oxybate • Armodafinil • Others
By Others • Mattresses and Pillows • Chin Straps • Mouth Pieces and Nasal Devices
By Indication • Insomnia • Sleep Deprivation • Narcolepsy • Sleep Apnea • Others
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
Key Market Players: • Pfizer Inc. • ResMed Inc. • Merck & Co. Inc. • GlaxoSmithKline Plc. • Fisher and Paykel Healthcare • EarlySense Ltd. • SleepMed
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the global sleeping aids market by Product Type, By Narcolepsy Treatment Drugs, By Others, by Indication and by Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and Latin America • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Sleeping Aids Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Sleeping Aids Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Sleeping Aids Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Sleeping Aids Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Sleeping Aids Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1 Insomnia Treatment Drugs 7.2 Doxepin Hydrochloride 7.3 Eszopiclone 7.4 Ramelteon 7.5 Triazolam 7.6 Zaleplon 7.7 Quazepam 7.8 Others 8. Global Sleeping Aids Market, By Indication Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Insomnia 8.2. Sleep Deprivation 8.3. Narcolepsy 8.4. Sleep Apnea 8.5. Others 9. Global Sleeping Aids Market, By Narcolepsy Treatment Drugs Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Modafinil 9.2. Sodium Oxybate 9.3. Armodafinil 9.4. Others 10. Global Sleeping Aids Market, By Others Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Mattresses and Pillows 10.2. Chin Straps 10.3. Mouth Pieces and Nasal Devices 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1 Pfizer Inc. 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 ResMed Inc. 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Merck & Co. Inc. 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 GlaxoSmithKline Plc. 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Fisher and Paykel Healthcare 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 EarlySense Ltd. 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 SleepMed 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 17 Impact of COVID-19 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. Competitive Intelligence and Competitive Matrix 18.1 Competitive Intelligence 18.2 Competitive Matrix 19. Major Deals and Strategic Alliances Analysis 19.1 Joint ventures 19.2 Mergers and acquisitions 19.3 Licensing and partnerships 19.4 Technology Collaborations 19.5 Strategic Divestments 19.6 Market Entry Strategies 20. Relevant Case Studies and Latest News Updates 21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Years Considered for the Study
1.3.2. Market Covered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data
2.1.2.1. Key Data from Primary Sources
2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation
2.4. Assumptions for the Study
3. Executive Summary
3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Sleeping Aids Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Global Sleeping Aids Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Sleeping Aids Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Sleeping Aids Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Sleeping Aids Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
7.1 Insomnia Treatment Drugs
7.2 Doxepin Hydrochloride
7.3 Eszopiclone
7.4 Ramelteon 7.5 Triazolam
7.6 Zaleplon
7.7 Quazepam 7.8 Others 8. Global Sleeping Aids Market, By Indication Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Insomnia
8.2. Sleep Deprivation
8.3. Narcolepsy
8.4. Sleep Apnea
8.5. Others
9. Global Sleeping Aids Market, By Narcolepsy Treatment Drugs Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Modafinil
9.2. Sodium Oxybate 9.3. Armodafinil 9.4. Others
10. Global Sleeping Aids Market, By Others Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Mattresses and Pillows 10.2. Chin Straps 10.3. Mouth Pieces and Nasal Devices
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Brazil
12.2.2. Venezuela
12.2.3. Argentina
12.2.4. Rest of Latin America
12.3. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Rest of Europe
13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Japan
14.2.2. China
14.2.3. India
14.2.4. Australia and New Zealand
14.2.5. ASEAN
14.2.6. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
15.2.1. Saudi Arabia
15.2.2. UAE
15.2.3. South Africa
15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
16.1 Pfizer Inc.
16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.2. Product Portfolio
16.1.3. SWOT Analysis
16.1.4. Financial Overview
16.1.5. Strategic Overview
16.2 ResMed Inc.
16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2. Product Portfolio
16.2.3. SWOT Analysis
16.2.4. Financial Overview
16.2.5. Strategic Overview
16.3 Merck & Co. Inc.
16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2. Product Portfolio
16.3.3. SWOT Analysis
16.3.4. Financial Overview
16.3.5. Strategic Overview
16.4 GlaxoSmithKline Plc.
16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.2. Product Portfolio
16.4.3. SWOT Analysis
16.4.4. Financial Overview
16.4.5. Strategic Overview
16.5 Fisher and Paykel Healthcare
16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.2. Product Portfolio
16.5.3. SWOT Analysis
16.5.4. Financial Overview
16.5.5. Strategic Overview
16.6 EarlySense Ltd.
16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.6.2. Product Portfolio
16.6.3. SWOT Analysis
16.6.4. Financial Overview
16.6.5. Strategic Overview
16.7 SleepMed
16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.7.2. Product Portfolio
16.7.3. SWOT Analysis
16.7.4. Financial Overview
16.7.5. Strategic Overview
17 Impact of COVID-19
17.1. Positive influence on the healthcare industry
17.2. The financial disruption of the manufacturing sector
17.3. Impact of COVID-19 on emerging companies
17.4. Significant mandates in the healthcare regulations initiated by administrations
17.5. The overall economic slowdown of the developing and developed nations
18. Competitive Intelligence and Competitive Matrix
18.1 Competitive Intelligence
18.2 Competitive Matrix
19. Major Deals and Strategic Alliances Analysis
19.1 Joint ventures
19.2 Mergers and acquisitions
19.3 Licensing and partnerships
19.4 Technology Collaborations
19.5 Strategic Divestments
19.6 Market Entry Strategies
20. Relevant Case Studies and Latest News Updates
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics